Part identity
NDC61958-0101-01
Cidofovirinjection
Gilead Sciences Ltd
Avg quote: 14 minFulfilled from Anaheim, CAAS9120:2025 · ISO 9001 · FAA AC 00-56BC of C, lot & date code with every line
Part description
Cidofovirinjection
ASAP supports this specific part for replacement, spare-pool replenishment, retrofit, and urgent maintenance requirements. Quote requests can include alternate MPN, condition preferences, certification needs, and plant-specific receiving instructions so procurement gets a clear sourcing response before purchase.
Specifications
Certifications & documentation
- UL Recognized
- CE
- C of C available on request
GS
Manufacturer
Gilead Sciences Ltd
Authorized-distributor or qualified-aftermarket source. Parts shipped from this manufacturer include full traceability paperwork and counterfeit-mitigation per SAE AS6081.
View manufacturer profile →NSN Information for Part Number NDC61958-0101-01 with NSN 6505-01-501-0628, 6505015010628
Characteristics Data of NSN 6505-01-501-0628, 6505015010628
| MRC | Criteria | Characteristic |
|---|---|---|
| AGAV | END ITEM IDENTIFICATION | FOR THE TREATMENT OF CYTOMEGALOVIRUS (CMV) RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYDROME (AIDS) |
| AJUC | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 081800 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CIDOFOVIR INJECTION 375MG ANHYDROUS 5ML AQUEOUS CONCENTRATION 75MG/MLVIAL |
| FEAT | SPECIAL FEATURES | SUPPLIED IN A CLEAR GLASS VIAL, EACH CONTAINING 375 MG OF ANHYDROUS CIDOFOVIR IN 5 ML AQUEOUS SOLUTION AT A CONCENTRAION OF 75 MG/ML; STERILE; SINGLE DOSE VIAL; PRESERVATIVE FREE; INTRAVENOUS USE ONLY; STORE AT CONTROLLED ROOM TEMPERATURE 2 |